"I've been 95% safe": perspectives on HIV pre-exposure prophylaxis at a drug detoxification center: a qualitative study

Pre-exposure prophylaxis (PrEP) decreases human immunodeficiency virus (HIV) acquisition among persons who inject drugs (PWID); however, its uptake has been suboptimal. We explored HIV risk perceptions and PrEP interest among drug detoxification center patients in the context of the ongoing opioid o...

Full description

Saved in:
Bibliographic Details
Published in:AIDS care Vol. 35; no. 4; pp. 461 - 465
Main Authors: Massey, Eugene S. G., Bazzi, Angela R., Sian, Carlos R., Gebel, Christina M., Bernstein, Judith A., Assoumou, Sabrina A.
Format: Journal Article
Language:English
Published: England Taylor & Francis 03-04-2023
Taylor & Francis Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pre-exposure prophylaxis (PrEP) decreases human immunodeficiency virus (HIV) acquisition among persons who inject drugs (PWID); however, its uptake has been suboptimal. We explored HIV risk perceptions and PrEP interest among drug detoxification center patients in the context of the ongoing opioid overdose epidemic. We conducted in-depth interviews of patients (n = 24) and professional key informants (n = 10 physicians, case managers, nurses, and harm reduction educators), and thematic analysis of coded data. The mean age of participants (patients) was 37 years; 54% identified as male and 67% as White. Although 71% reported injecting drugs and 62% had condomless sex in the past 6 months, participants had mixed HIV risk perceptions, and some viewed PrEP as an undesirable indicator of elevated HIV risk. Nevertheless, many participants viewed drug detoxification as a first step towards embarking on a "healthier lifestyle," with some narratives identifying opportunities for delivering PrEP information and services in this setting. Opportunities exist to expand PrEP at drug detoxification centers, but initiatives are needed to educate patients and staff on indications and benefits of this prevention tool. Interventions are also needed to determine the best strategies for implementing PrEP adoption in this setting.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Judith A. Bernstein, PhD, Emeritus Professor, Boston University School of Public Health, Dept of Community Health Sciences, 801 Massachusetts Ave Crosstown Center, Boston MA 02118, P: 617-414-1415
Angela R. Bazzi, PhD, MPH, Dept of Community Health Sciences, Boston University School of Public Health, 801 Massachusetts Ave Crosstown Center, Boston MA 02118
Christina M. Gebel, MPH, Dept of Community Health Sciences, Boston University School of Public Health, 801 Massachusetts Ave Crosstown Center, Boston MA 02118
Eugene Massey, BA, Dept of Community Health Sciences, Boston University School of Public Health, 801 Massachusetts Ave Crosstown Center, Boston MA 02118, P: 617-638-5160
Carlos R. Sian, MPH, Section of Infectious Diseases, Boston Medical Center, 801 Massachusetts Ave. Crosstown Center, 2nd Floor Boston, MA 02118
ISSN:0954-0121
1360-0451
DOI:10.1080/09540121.2022.2031853